Replies to post #37491 on Ayala Pharmaceuticals Inc (ADXS)

[CATTDOGG12347]

I think selling NEO to Amgen might actually put pressure on the rest of the pack to acquire HOT. We will also get to profit from NEO as well along the development path and once approved. IMO there are two jewels in the crown, NEO and HOT with HOT being the most valuable.

[ignatiusrielly35]

Completely disagree. Licensing individual indications is far preferable at this time compared to diluting the entire enterprise at ridiculous, suppressed share prices.

[Traderbx]

A valid point terry, if I was running something personally, it would break my heart to sell a partnership where my profit share would be lost forever....

But at the same time, partnerships provide upfront cash and share of the same business risk....

Also, If I have a choice of partnership vs. dilution when stock is at yearly lows.... it would be silly to dilute